According to NHA, 59 million hospitalisations worth Rs. 74,000 crore (US$ 8.88 billion) authorised under AB-PMJAY since 2018
According to the National Health Authority (NHA), over 59 million hospital admissions have been made at a cost of more than Rs 74,000 crore under the Centre's flagship health insurance policy Ayushman Bharat Pradhan Mantri Jan Aarogya Yojana (AB-PMJAY) since its inception (2018) five years ago.
On September 23rd, 2018, Prime Minister Mr. Narendra Modi announced the initiative. It guarantees Rs. 5 lakh (US$ 6,005.11) per year for every household, guaranteeing that decent healthcare is available to the country's low-income earners.
Since the scheme's inception, more than 59 million hospital admissions have been allowed in Ranchi at a cost of Rs 74,131.79 crore (US$ 8.90 billion), according to the NHA's website.
According to the AB-PMJAY data, general medicine is the most frequently consulted speciality, with over 11 million patients. It is followed by infectious diseases (4.31 million consultations), general surgery (3.07 million consultations), and medical oncology (2.50 million consultations), according to the report.
Since the scheme's inception, the top six consultation specialisations have cost the government a total of Rs 15,651.89 crore (US$ 1.87 billion). According to the NHA, the scheme's main goals are to provide complete coverage for catastrophic illnesses, reduce out-of-pocket costs, and enhance hospitalisation accessibility.
The scheme currently offers 919 Health Benefits Packages (HBPs), which cover 1,670 operations across 26 specialities. General surgery has the most HBPs (105), while medical oncology has the most procedures (264).
According to NHA data, haemodialysis is the most performed procedure in hospitals enrolled in the system, with almost 6 million cases totalling Rs. 2,521.58 crore (US$ 302.84 million). It is followed by Percutaneous Transluminal Coronary Angioplasty (PTCA) in two alternatives: with and without a single stent. Both surgeries have a total cost of Rs. 2,627.48 crore (US$ 315.56 million).
Disclaimer: This information has been collected through secondary research and IBEF is not responsible for any errors in the same.